INHIBIDORES DE LA PROTEASA NS3 DEL HCV
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS MACROCICLICOS DE FORMULA (I) QUE SON UTIELES COMO INHIBIDORES DE LA PROTEASA NS3 DEL VIRUS DE LA HEPATITIS C (HCV), A SU SINTESIS Y A SU USO PARA TRATAR O PREVENIR INFECCIONES CON HCV The present invention relates to macrocyclic compounds of formula (I)...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ALESSIA PETROCCHI CHARLES J. MCINTYRE MICHAEL T. RUDD BUTCHER JOHN W MARCO POMPEI STEVEN HARPPER NIGEL J. LIVERTON MARIA EMILIAFRANCESCO HOLLOWAY M. KATHARINE JOHN A. MCCAULEY JOSEPH J.ROMANO KEVIN F. GILBERT VINCENZO SUMMA MARCO FERRARA |
| description | LA PRESENTE INVENCION SE REFIERE A COMPUESTOS MACROCICLICOS DE FORMULA (I) QUE SON UTIELES COMO INHIBIDORES DE LA PROTEASA NS3 DEL VIRUS DE LA HEPATITIS C (HCV), A SU SINTESIS Y A SU USO PARA TRATAR O PREVENIR INFECCIONES CON HCV
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HN2009000792A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HN2009000792A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HN2009000792A3</originalsourceid><addsrcrecordid>eNrjZFDz9PPwdPJ08Q9yDVZwcVXwcVQICPIPcXUMdlTwCzYGCvkoeDiH8TCwpiXmFKfyQmluBiU31xBnD93Ugvz41OKCxOTUvNSSeA8_IwMDSwMDA3NLI0djohQBAM51I2I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>INHIBIDORES DE LA PROTEASA NS3 DEL HCV</title><source>esp@cenet</source><creator>ALESSIA PETROCCHI ; CHARLES J. MCINTYRE ; MICHAEL T. RUDD ; BUTCHER JOHN W ; MARCO POMPEI ; STEVEN HARPPER ; NIGEL J. LIVERTON ; MARIA EMILIAFRANCESCO ; HOLLOWAY M. KATHARINE ; JOHN A. MCCAULEY ; JOSEPH J.ROMANO ; KEVIN F. GILBERT ; VINCENZO SUMMA ; MARCO FERRARA</creator><creatorcontrib>ALESSIA PETROCCHI ; CHARLES J. MCINTYRE ; MICHAEL T. RUDD ; BUTCHER JOHN W ; MARCO POMPEI ; STEVEN HARPPER ; NIGEL J. LIVERTON ; MARIA EMILIAFRANCESCO ; HOLLOWAY M. KATHARINE ; JOHN A. MCCAULEY ; JOSEPH J.ROMANO ; KEVIN F. GILBERT ; VINCENZO SUMMA ; MARCO FERRARA</creatorcontrib><description>LA PRESENTE INVENCION SE REFIERE A COMPUESTOS MACROCICLICOS DE FORMULA (I) QUE SON UTIELES COMO INHIBIDORES DE LA PROTEASA NS3 DEL VIRUS DE LA HEPATITIS C (HCV), A SU SINTESIS Y A SU USO PARA TRATAR O PREVENIR INFECCIONES CON HCV
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.</description><language>spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110823&DB=EPODOC&CC=HN&NR=2009000792A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20110823&DB=EPODOC&CC=HN&NR=2009000792A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ALESSIA PETROCCHI</creatorcontrib><creatorcontrib>CHARLES J. MCINTYRE</creatorcontrib><creatorcontrib>MICHAEL T. RUDD</creatorcontrib><creatorcontrib>BUTCHER JOHN W</creatorcontrib><creatorcontrib>MARCO POMPEI</creatorcontrib><creatorcontrib>STEVEN HARPPER</creatorcontrib><creatorcontrib>NIGEL J. LIVERTON</creatorcontrib><creatorcontrib>MARIA EMILIAFRANCESCO</creatorcontrib><creatorcontrib>HOLLOWAY M. KATHARINE</creatorcontrib><creatorcontrib>JOHN A. MCCAULEY</creatorcontrib><creatorcontrib>JOSEPH J.ROMANO</creatorcontrib><creatorcontrib>KEVIN F. GILBERT</creatorcontrib><creatorcontrib>VINCENZO SUMMA</creatorcontrib><creatorcontrib>MARCO FERRARA</creatorcontrib><title>INHIBIDORES DE LA PROTEASA NS3 DEL HCV</title><description>LA PRESENTE INVENCION SE REFIERE A COMPUESTOS MACROCICLICOS DE FORMULA (I) QUE SON UTIELES COMO INHIBIDORES DE LA PROTEASA NS3 DEL VIRUS DE LA HEPATITIS C (HCV), A SU SINTESIS Y A SU USO PARA TRATAR O PREVENIR INFECCIONES CON HCV
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDz9PPwdPJ08Q9yDVZwcVXwcVQICPIPcXUMdlTwCzYGCvkoeDiH8TCwpiXmFKfyQmluBiU31xBnD93Ugvz41OKCxOTUvNSSeA8_IwMDSwMDA3NLI0djohQBAM51I2I</recordid><startdate>20110823</startdate><enddate>20110823</enddate><creator>ALESSIA PETROCCHI</creator><creator>CHARLES J. MCINTYRE</creator><creator>MICHAEL T. RUDD</creator><creator>BUTCHER JOHN W</creator><creator>MARCO POMPEI</creator><creator>STEVEN HARPPER</creator><creator>NIGEL J. LIVERTON</creator><creator>MARIA EMILIAFRANCESCO</creator><creator>HOLLOWAY M. KATHARINE</creator><creator>JOHN A. MCCAULEY</creator><creator>JOSEPH J.ROMANO</creator><creator>KEVIN F. GILBERT</creator><creator>VINCENZO SUMMA</creator><creator>MARCO FERRARA</creator><scope>EVB</scope></search><sort><creationdate>20110823</creationdate><title>INHIBIDORES DE LA PROTEASA NS3 DEL HCV</title><author>ALESSIA PETROCCHI ; CHARLES J. MCINTYRE ; MICHAEL T. RUDD ; BUTCHER JOHN W ; MARCO POMPEI ; STEVEN HARPPER ; NIGEL J. LIVERTON ; MARIA EMILIAFRANCESCO ; HOLLOWAY M. KATHARINE ; JOHN A. MCCAULEY ; JOSEPH J.ROMANO ; KEVIN F. GILBERT ; VINCENZO SUMMA ; MARCO FERRARA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HN2009000792A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ALESSIA PETROCCHI</creatorcontrib><creatorcontrib>CHARLES J. MCINTYRE</creatorcontrib><creatorcontrib>MICHAEL T. RUDD</creatorcontrib><creatorcontrib>BUTCHER JOHN W</creatorcontrib><creatorcontrib>MARCO POMPEI</creatorcontrib><creatorcontrib>STEVEN HARPPER</creatorcontrib><creatorcontrib>NIGEL J. LIVERTON</creatorcontrib><creatorcontrib>MARIA EMILIAFRANCESCO</creatorcontrib><creatorcontrib>HOLLOWAY M. KATHARINE</creatorcontrib><creatorcontrib>JOHN A. MCCAULEY</creatorcontrib><creatorcontrib>JOSEPH J.ROMANO</creatorcontrib><creatorcontrib>KEVIN F. GILBERT</creatorcontrib><creatorcontrib>VINCENZO SUMMA</creatorcontrib><creatorcontrib>MARCO FERRARA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ALESSIA PETROCCHI</au><au>CHARLES J. MCINTYRE</au><au>MICHAEL T. RUDD</au><au>BUTCHER JOHN W</au><au>MARCO POMPEI</au><au>STEVEN HARPPER</au><au>NIGEL J. LIVERTON</au><au>MARIA EMILIAFRANCESCO</au><au>HOLLOWAY M. KATHARINE</au><au>JOHN A. MCCAULEY</au><au>JOSEPH J.ROMANO</au><au>KEVIN F. GILBERT</au><au>VINCENZO SUMMA</au><au>MARCO FERRARA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>INHIBIDORES DE LA PROTEASA NS3 DEL HCV</title><date>2011-08-23</date><risdate>2011</risdate><abstract>LA PRESENTE INVENCION SE REFIERE A COMPUESTOS MACROCICLICOS DE FORMULA (I) QUE SON UTIELES COMO INHIBIDORES DE LA PROTEASA NS3 DEL VIRUS DE LA HEPATITIS C (HCV), A SU SINTESIS Y A SU USO PARA TRATAR O PREVENIR INFECCIONES CON HCV
The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_HN2009000792A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | INHIBIDORES DE LA PROTEASA NS3 DEL HCV |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T17%3A08%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ALESSIA%20PETROCCHI&rft.date=2011-08-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHN2009000792A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |